| Primary |
| Thermal Burn |
26.5% |
| Asthma |
5.9% |
| Breast Cancer |
5.9% |
| Hypertension |
5.9% |
| Localised Infection |
5.9% |
| Pain |
5.9% |
| Sepsis |
5.9% |
| Type 2 Diabetes Mellitus |
5.9% |
| Cellulitis |
4.4% |
| Post Procedural Infection |
4.4% |
| Bone Marrow Failure |
2.9% |
| Decubitus Ulcer |
2.9% |
| Multiple Sclerosis |
2.9% |
| Premedication |
2.9% |
| Rash |
2.9% |
| Systemic Lupus Erythematosus |
2.9% |
| Burns Third Degree |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Epidermolysis Bullosa |
1.5% |
| Infection |
1.5% |
|
| Skin Discolouration |
21.1% |
| Drug Effect Decreased |
7.9% |
| Application Site Discolouration |
5.3% |
| Drug Hypersensitivity |
5.3% |
| Eye Irritation |
5.3% |
| Skin Exfoliation |
5.3% |
| Skin Injury |
5.3% |
| Skin Ulcer |
5.3% |
| Urticaria |
5.3% |
| Vomiting |
5.3% |
| Wrong Technique In Drug Usage Process |
5.3% |
| Argyria |
2.6% |
| Blister |
2.6% |
| Insomnia |
2.6% |
| Maternal Exposure During Pregnancy |
2.6% |
| Off Label Use |
2.6% |
| Skin Disorder |
2.6% |
| Skin Necrosis |
2.6% |
| Sunburn |
2.6% |
| Therapeutic Response Unexpected |
2.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
16.7% |
| Localised Infection |
16.7% |
| Sepsis |
12.1% |
| Asthma |
9.1% |
| Multiple Sclerosis |
8.3% |
| Hypertension |
6.8% |
| Post Procedural Infection |
6.8% |
| Systemic Lupus Erythematosus |
5.3% |
| Premedication |
4.5% |
| Product Used For Unknown Indication |
3.0% |
| Acute Lymphocytic Leukaemia |
2.3% |
| Febrile Neutropenia |
1.5% |
| Pain |
1.5% |
| Drug Toxicity |
0.8% |
| Epidermolysis Bullosa |
0.8% |
| Gastrointestinal Haemorrhage |
0.8% |
| Nausea |
0.8% |
| Ph Urine Abnormal |
0.8% |
| Pharyngitis Streptococcal |
0.8% |
| Pulmonary Arterial Hypertension |
0.8% |
|
| Systemic Lupus Erythematosus |
22.7% |
| Transaminases Increased |
18.2% |
| Drug Hypersensitivity |
13.6% |
| Argyria |
4.5% |
| Diarrhoea |
4.5% |
| Insomnia |
4.5% |
| Muscle Twitching |
4.5% |
| Rash |
4.5% |
| Skin Ulcer |
4.5% |
| Stomatitis |
4.5% |
| Synovial Cyst |
4.5% |
| Treatment Failure |
4.5% |
| Wound |
4.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.2% |
| Drug Use For Unknown Indication |
13.3% |
| Pain |
9.4% |
| Breast Cancer |
7.0% |
| Medical Diet |
4.8% |
| Anxiety |
4.7% |
| Non-small Cell Lung Cancer |
4.1% |
| Nausea |
3.6% |
| Depression |
2.9% |
| Prophylaxis |
2.8% |
| Diarrhoea |
2.5% |
| Anaemia |
2.3% |
| Headache |
2.2% |
| Attention Deficit/hyperactivity Disorder |
1.9% |
| Hypertension |
1.9% |
| Thrombocytopenia |
1.8% |
| Rheumatoid Arthritis |
1.6% |
| Constipation |
1.4% |
| Fatigue |
1.3% |
| Multiple Allergies |
1.3% |
|
| Vomiting |
12.2% |
| Wound Complication |
12.2% |
| Thrombocytopenia |
9.8% |
| Wound Infection |
8.5% |
| White Blood Cell Count Decreased |
6.1% |
| Drug Effect Decreased |
4.9% |
| Skin Ulcer |
4.9% |
| Staphylococcal Infection |
4.9% |
| Disease Progression |
3.7% |
| Pain |
3.7% |
| Thermal Burn |
3.7% |
| Transfusion Reaction |
3.7% |
| Upper Respiratory Tract Infection |
3.7% |
| Weight Increased |
3.7% |
| Accidental Overdose |
2.4% |
| Arthralgia |
2.4% |
| Bronchitis |
2.4% |
| Dyspnoea |
2.4% |
| Fatigue |
2.4% |
| Infection |
2.4% |
|
